Revenue (TTM) Chart

View Revenue (TTM) for KRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 1.943B
March 31, 2026 1.879B
December 31, 2025 1.859B
September 30, 2025 1.864B
June 30, 2025 1.892B
March 31, 2025 1.898B
December 31, 2024 1.887B
September 30, 2024 1.864B
June 30, 2024 1.776B
March 31, 2024 1.719B
December 31, 2023 1.666B
September 30, 2023 1.609B
June 30, 2023 1.672B
March 31, 2023 1.794B
December 31, 2022 1.930B
September 30, 2022 2.084B
June 30, 2022 2.124B
March 31, 2022 2.037B
December 31, 2021 1.939B
September 30, 2021 1.858B
June 30, 2021 1.775B
March 31, 2021 1.683B
December 31, 2020 1.639B
September 30, 2020 1.597B
June 30, 2020 1.617B
Date Value
March 31, 2020 1.716B
December 31, 2019 1.731B
September 30, 2019 1.708B
June 30, 2019 1.681B
March 31, 2019 1.668B
December 31, 2018 1.662B
September 30, 2018 1.766B
June 30, 2018 1.82B
March 31, 2018 1.790B
December 31, 2017 1.729B
September 30, 2017 1.609B
June 30, 2017 1.501B
March 31, 2017 1.416B
December 31, 2016 1.364B
September 30, 2016 1.318B
June 30, 2016 1.298B
March 31, 2016 1.302B
December 31, 2015 1.349B
September 30, 2015 1.435B
June 30, 2015 1.514B
March 31, 2015 1.597B
December 31, 2014 1.652B
September 30, 2014 1.647B
June 30, 2014 1.651B
March 31, 2014 1.689B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Albemarle Corp. 5.908B
Avient Corp. 3.332B
The Chemours Co. 5.797B
Air Products & Chemicals, Inc. 12.60B
Cabot Corp. 3.634B